Raymond James Financial Services Advisors, Inc. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,487,310
-35.9%
134,355
-6.2%
0.00%
-25.0%
Q2 2023$2,321,337
+34.9%
143,204
+38.6%
0.00%
+33.3%
Q1 2023$1,720,728
+42.2%
103,347
-19.7%
0.00%
+50.0%
Q4 2022$1,209,846
+210.2%
128,707
-10.1%
0.00%
+100.0%
Q3 2022$390,000
-4.6%
143,207
+1.1%
0.00%0.0%
Q2 2022$409,000
-5.8%
141,581
-2.0%
0.00%0.0%
Q1 2022$434,000
-46.6%
144,532
-18.2%
0.00%
-50.0%
Q4 2021$813,000
-28.7%
176,649
-2.7%
0.00%0.0%
Q3 2021$1,140,000
+17.0%
181,523
+11.6%
0.00%0.0%
Q2 2021$974,000
-5.8%
162,663
-0.5%
0.00%0.0%
Q1 2021$1,034,000
+36.2%
163,433
+21.2%
0.00%0.0%
Q4 2020$759,000
+15.0%
134,845
+19.0%
0.00%0.0%
Q3 2020$660,000
-25.7%
113,340
-8.0%
0.00%
-33.3%
Q2 2020$888,000
+126.0%
123,138
+46.6%
0.00%
+50.0%
Q1 2020$393,000
-31.3%
84,002
+17.7%
0.00%0.0%
Q4 2019$572,000
+16.0%
71,348
-0.4%
0.00%0.0%
Q3 2019$493,000
+25.1%
71,649
+50.9%
0.00%0.0%
Q2 2019$394,000
+14.2%
47,478
+36.8%
0.00%
+100.0%
Q1 2019$345,000
+102.9%
34,714
+55.9%
0.00%0.0%
Q4 2018$170,00022,2610.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders